POLYMED

Poly Medicure Share Price

₹2,386.80 -132.75 (-5.27%)

22 Jan, 2025 12:08

SIP TrendupStart SIP in POLYMED

Start SIP

Performance

  • Low
  • ₹2,343
  • High
  • ₹2,525
  • 52 Week Low
  • ₹1,361
  • 52 Week High
  • ₹3,358
  • Open Price₹2,500
  • Previous Close₹2,520
  • Volume84,153

Investment Returns

  • Over 1 Month -8.05%
  • Over 3 Month -2.6%
  • Over 6 Month + 15.09%
  • Over 1 Year + 65.1%
SIP Lightning

Smart Investing Starts Here Start SIP with Poly Medicure for Steady Growth!

Invest Now

Poly Medicure Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 82
  • PEG Ratio
  • 3.1
  • Market Cap Cr
  • 24,184
  • P/B Ratio
  • 9.3
  • Average True Range
  • 94.44
  • EPS
  • 29.1
  • Dividend Yield
  • 0.1
  • MACD Signal
  • -35.79
  • RSI
  • 39.89
  • MFI
  • 44.16

Poly Medicure Financials

Poly Medicure Technicals

EMA & SMA

Current Price
₹2,386.80
-132.75 (-5.27%)
pointer
  • stock-down_img
  • Bearish Moving Average 14
  • stock-up_img
  • Bullish Moving Average 2
  • 20 Day
  • ₹2,617.28
  • 50 Day
  • ₹2,644.25
  • 100 Day
  • ₹2,542.57
  • 200 Day
  • ₹2,293.06

Resistance and Support

2521.62 Pivot Speed
  • R3 2,588.53
  • R2 2,566.92
  • R1 2,543.23
  • S1 2,497.93
  • S2 2,476.32
  • S3 2,452.63

What's your outlook on Poly Medicure?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Poly Medicure Ltd. is a leading Indian manufacturer of medical devices, specializing in infusion therapy, dialysis, urology, and diagnostics. With 8 global manufacturing facilities, it delivers high-quality healthcare products to patients and healthcare providers worldwide.

Poly Medicure has an operating revenue of Rs. 1,522.46 Cr. on a trailing 12-month basis. An annual revenue growth of 25% is outstanding, Pre-tax margin of 25% is great, ROE of 17% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its 50DMA and around 13% up from its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 87 which is a GOOD score indicating consistency in earnings, a RS Rating of 80 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at C+ which is evident from recent supply seen, Group Rank of 26 indicates it belongs to a strong industry group of Medical-Systems/Equip and a Master Score of B is close to being the best. Overall, the stock has great fundamentals and technical strength to stay in momentum.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Poly Medicure Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-10-28 Quarterly Results & ESOP
2024-07-22 Quarterly Results
2024-06-29 Others Inter alia, to consider and finalize the terms and condition and approve the modes of fund raising. per share(40%)Interim Dividend
2024-05-17 Audited Results & Final Dividend
2024-03-08 Others Inter alia, to consider a) Business Plan for Financial Year 2024-25. b) To consider and evaluate a proposal for raising of funds, in one or more tranches, through permissible mode(s). per share(40%)Interim Dividend

Poly Medicure F&O

Poly Medicure Shareholding Pattern

62.44%
7.17%
2.44%
12.33%
10.55%
5.07%

About Poly Medicure

  • NSE Symbol
  • POLYMED
  • BSE Symbol
  • 531768
  • Managing Director
  • Mr. Himanshu Baid
  • ISIN
  • INE205C01021

Similar Stocks to Poly Medicure

Poly Medicure FAQs

Poly Medicure share price is ₹2,386 As on 22 January, 2025 | 11:54

The Market Cap of Poly Medicure is ₹24184.4 Cr As on 22 January, 2025 | 11:54

The P/E ratio of Poly Medicure is 82 As on 22 January, 2025 | 11:54

The PB ratio of Poly Medicure is 9.3 As on 22 January, 2025 | 11:54

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23